Skip to main content

Table 3 Clinical and echocardiographic characteristics of study population at follow-up

From: Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up

  Overall (N = 134) RTF progression (N = 39) No FTR progression (N = 94) p value for trend
Age, years; mean ± SD (range) 59.7 ± 11.5
[30–94]
60.5 ± 12.5
[38–94]
59.3 ± 11.2
[30–89]
0.356
Gender (Male) 105 (78.4) 32 (82.1) 73 (76.8) 0.06
LA Area, mm (Range) 39.53 ± 9.2
[20–73]
42.9 ± 10.6
[23–73]
35.61 ± 7.0
[20–53]
0.06
LVIDD, mm 56.2 ± 7.2
[42–72]
58.9 ± 7.3
[43–70]
53.1 ± 6.1
[42–64]
0.05
LVEF, % 45.1 ± 10.2
[20–65]
40. 1 ± 10.3
[20–58]
50.6 ± 7.3
[30–65]
 < 0.0001
RV FAC, % 27.0 ± 6.1
[10–38]
23.1 ± 6.9
[10–37]
30.50 ± 3.8
[23–38]
0.002
RV dysfunction > 2, n (%) 40 (29.9) 22 (56.4) 3 (4.2)  < 0.0001
Mean sPAP, mm Hg 38.5 ± 12.3
[19–66]
43.6 ± 11.62
[22–65]
31.6 ± 8.4
[19–59]
 < 0.0001
PHT ≥ Moderate, n (%) 51 (38.1) 23 (59) 9 (12.5) 0.001
MR > 2, n (%) 46 (34.3) 36 (78.3) 10 (11.4)  < 0.0001
Echocardiographic Groupa  < 0.0001
Group 1   0 (0) 32 (69.6)  
Group 2   5 (5.7) 4 (8.7)  
Group 3   9 (10.2) 5 (10.9)  
Group 4   74 (84.1) 5 (10.5)  
  1. Overall and by FTR development grade
  2. R = .917, R2 = .842. No multicollinearity was observed
  3. LVIDD indicates left ventricular internal diameter at end-diastolic phase; LVEF left ventricular ejection fraction; RV FAC, Right ventricular fractional area change; sPAP, systolic pulmonary artery pressure; PHT, Pulmonary Hypertension; MR, mitral regurgitation
  4. asee Table 4 for reference